false 0001102942 0001102942 2024-04-16 2024-04-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 or 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): April 16, 2024

 

InnovaQor, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada

(State or Other Jurisdiction of Incorporation)

 

000-33191   84-0436055
(Commission File Number)   (I.R.S. Employer Identification No.)

 

400 South Australian Avenue, Suite 800, West Palm Beach,
Florida		   33401
(Address of Principal Executive Offices)   (Zip Code)

 

(561) 421-1900
(Registrant’s Telephone Number, Including Area Code)

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered under Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On April 16, 2024, Darrell L. Peterson, the Chief Executive Officer and President and a Director of InnovaQor, Inc. (the “Company”) and certain subsidiaries, resigned from these positions. Mr. Peterson did not express any disagreement with the Company in any matter relating to the Company’s operations, policies or practices. The Company is currently conducting a search for a successor to Mr. Peterson and has appointed Justin Doherty, a Director of the Company, as Interim Chief Executive Officer until a successor is found.

 

Item 9.01. Financial Statements and Exhibits

 

  (d) Exhibits

 

Exhibit No.   Exhibit Description
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 26, 2024 INNOVAQOR, INC.
     
  By: /s/ Gerard Dab
    Gerard Dab
    Chairman and Secretary

 

3

 

v3.24.1.u1
Cover
Apr. 16, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 16, 2024
Entity File Number 000-33191
Entity Registrant Name InnovaQor, Inc.
Entity Central Index Key 0001102942
Entity Tax Identification Number 84-0436055
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 400 South Australian Avenue
Entity Address, Address Line Two Suite 800
Entity Address, City or Town West Palm Beach
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33401
City Area Code 561
Local Phone Number 421-1900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas VisualMED Clinical Solut... (PK).
VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas VisualMED Clinical Solut... (PK).